Welcome to Lupus Awareness Month The Lupus Research Alliance celebrates the strength, passion and optimism that marks people with lupus and those who love them this May. As we share the extraordinary stories of four lupus warriors over the next few weeks, we want to hear all of your stories. Each […] READ MORE
April 26, 2018 Lupus Research Alliance and Lupus Therapeutics collaborate with Bristol-Myers Squibb on a New Lupus Trial The Lupus Research Alliance today announced a collaboration between its newly formed affiliate, Lupus Therapeutics, and the pharmaceutical company, Bristol-Myers Squibb (BMS), to test a novel investigational drug, BMS-986165, as a potential new therapy for […] READ MORE
April 24, 2018 Scientists funded by the Lupus Research Alliance may have discovered why patients with lupus are at risk for heart disease. Most recently, at the National Institute of Arthritis and Musculoskeletal and Skin Diseases, Dr. Mariana Kaplan and colleagues found that abnormal immune system cells are damaging patients’ arteries. Published in the journal […] READ MORE
April 20, 2018 The Lupus Research Alliance Lupus Industry Council (LIC) met a key objective with the recent publication in the medical journal Arthritis & Rheumatology reporting on a new tool to better measure the effectiveness of potential drug treatments in clinical trials. The LIC aims to bring industry and academia together to work collaboratively, […] READ MORE
April 18, 2018 A new study by Lupus Research Alliance-funded researcher Dr. Matthew Weirauch of the Cincinnati Children’s Hospital Medical Center in Ohio and colleagues might explain how a common virus that causes mononucleosis also boosts the risk for lupus. The virus may be turning on human genes that promote the illness. The scientists, including […] READ MORE
April 11, 2018 Nine Outstanding Investigators Receive Funding for Innovative Research on Lupus Causes, Pathways, and New Treatment Development Today, the Lupus Research Alliance announced nine new Novel Research Grants to support paradigm-changing lupus research. To conquer the complexity of lupus, the Novel Research Grants explore lupus from many perspectives, testing new theories about what […] READ MORE
April 5, 2018 A new clinical study published in the prestigious medical journal The Lancet found that sirolimus, a drug currently FDA approved to prevent organ transplant rejection, may offer a safe and effective treatment for lupus. In an accompanying editorial, Lupus Research Alliance Scientific Advisory Board Co-Chair Mary Crow, MD notes that in addition […] READ MORE
March 29, 2018 Selena Gomez’s first design collaboration with PUMA, is the highly anticipated Phenom Lux—a shoe that is made to stand out and help out. Designed for training, but styled for slaying, Phenom Lux allows women not only to perform, but also take action. For this important first design collaboration between Selena and PUMA, […] READ MORE
Source: Vogue, March 28, 2018 Selena Gomez is dipping a toe into sneaker design. Today, the singer revealed her first collaboration as brand ambassador for Puma. The sleek, all-white style, known as the Phenom Lux, comes with gold accents and a removable ankle bracelet, and is best worn with a pair of Puma’s new sheer […] READ MORE
March 26, 2018 Source: Ablynx Press Release 3.26.18 Ablynx today announced that the Phase II dose-ranging study of vobarilizumab, the Company’s anti-IL-6R Nanobody®, did not meet the primary endpoint of dose response based on the modified BILAG-based combined lupus assessment (mBICLA) at Week 24. The primary endpoint of the study was the percentage of subjects who […] READ MORE
March 23, 2018 The Omnibus Appropriations bill for Fiscal Year 2018 that passed today includes key provisions the Lupus Research Alliance and lupus advocates have worked for all year. Lupus advocates, participating just days before for our annual March Capitol Hill Day, had requested program funding for 2019 and had asked legislators to also finish […] READ MORE
March 21, 2018 Lupus Research Alliance-Funded Scientists Find Potential Target to Treat Kidney Disease Novel research initially funded by the Lupus Research Alliance through a grant to Hospital for Special Surgery scientists significantly advanced understanding of kidney damage in lupus. As reported by Hospital for Special Surgery: A protein that helps regulate the body’s […] READ MORE
because the Lupus Research Alliance board of directors funds all administrative and fundraising costs
